Expression of protective protein in human tissue.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Pediatric Neurology

• Publication date

  1999-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0887-8994(98)00151-9PMID 10207930
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Galactosialidosis: neuropathological findings in a case of the late-infantile type

  2004cited by this paper
• Neuropathological findings of an autopsy case of adult β-galactosidase and neuraminidase deficiency

  2004cited by this paper
• Distribution of lysosomal protective protein in human tissues.

  1994cited by this paper
• Purification and characterization of human lysosomal protective protein expressed in stably transformed Chinese hamster ovary cells.

  1993cited by this paper
• Protective protein gene mutations in galactosialidosis.

  1993cited by this paper
• Infantile galactosialidosis presenting with congenital adrenal hyperplasia and renal hypertension.

  1993cited by this paper
• Inactivation of endothelin I by deamidase (lysosomal protective protein).

  1992cited by this paper
• Galactosialidosis : clinical and molecular analysis of 19 Japanese patients

  1991cited by this paper
• Human lysosomal protective protein has cathepsin A-like activity distinct from its protective function.

  1991cited by this paper
• Abnormal glycosphingolipid metabolism in the nervous system of galactosialidosis.

  1990cited by this paper
• Structure of the lysosomal neuraminidase-beta-galactosidase-carboxypeptidase multienzymic complex.

  1990cited by this paper
• Galactosialidosis: simultaneous deficiency of esterase, carboxy-terminal deamidase and acid carboxypeptidase activities.

  1990cited by this paper
• A peptidase in human platelets that deamidates tachykinins. Probable identity with the lysosomal "protective protein".

  1990cited by this paper
• Mouse "protective protein". cDNA cloning, sequence comparison, and expression.

  1990cited by this paper
• Expression of cDNA encoding the human “protective protein≓ associated with lysosomal β-galactosidase and neuraminidase: Homology to yeast proteases

  1988cited by this paper
• Expression of cDNA encoding the human "protective protein" associated with lysosomal beta-galactosidase and neuraminidase: homology to yeast proteases.

  1988cited by this paper
• Galactosialidosis: molecular heterogeneity among distinct clinical phenotypes.

  1986cited by this paper
• Ultrastructural study on a severe infantile sialidosis (beta-galactosidase-alpha-neuraminidase deficiency).

  1985cited by this paper
• Ultrastructural study on a severe infantile sialidosis (β-galactosidase-α-neuraminidase deficiency)

  1985cited by this paper
• A severe infantile sialidosis (beta-galactosidase-alpha-neuraminidase deficiency) mimicking GM1-gangliosidosis type 1.

  1983cited by this paper
• β‐Galactosidase–neuraminidase deficiency (galactosialidosis): Clinical, pathological, and enzymatic studies in a postmortem case

  1983cited by this paper
• Molecular defect in combined beta-galactosidase and neuraminidase deficiency in man.

  1982cited by this paper
• Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles.

  1981cited by this paper
• Adult type neuronal storage disease with neuraminidase deficiency

  1979cited by this paper

• Exploring therapeutic and diagnostic potential of cysteine cathepsin as targets for cancer therapy with nanomedicine.

  2025cites this paper
• Mice with Catalytically Inactive Cathepsin A Display Neurobehavioral Alterations

  2017cites this paper
• Lysosomal Cathepsin A Plays a Significant Role in the Processing of Endogenous Bioactive Peptides

  2016cites this paper
• Tolerability, safety, and pharmacokinetics of the novel cathepsin A inhibitor SAR164653 in healthy subjects

  2016cites this paper
• INVESTIGATING THE REGULATORY ROLE OF LYSOSOMAL PROTEIN CATHEPSIN A IN VASOACTIVE PEPTIDE BIOLOGY

  2016cites this paper
• Lysosomal Carboxypeptidase A

  2013cites this paper
• Immunohistochemical study of microscopic globular bodies of normal human brain.

  2011cites this paper
• A case of galactosialidosis with a homozygous Q49R point mutation.

  2008cites this paper
• Structural alterations of epididymal epithelial cells in cathepsin A-deficient mice affect the blood-epididymal barrier and lead to altered sperm motility.

  2007cites this paper
• Enzymatic pathways of the brain renin–angiotensin system: Unsolved problems and continuing challenges

  2007cites this paper
• Cathepsin A Is the Major Hydrolase Catalyzing the Intracellular Hydrolysis of the Antiretroviral Nucleotide Phosphonoamidate Prodrugs GS-7340 and GS-9131

  2006cites this paper
• Proteases and Protease Inhibitors

  2005cites this paper
• Characterization of cell‐ and region‐specific abnormalities in the epididymis of cathepsin a deficient mice

  2003cites this paper
• Increase in macrophages in the testis of cathepsin a deficient mice suggests an important role for these cells in the interstitial space of this tissue

  2003cites this paper
• Cathepsin A Is Expressed in a Cell- and Region-specific Manner in the Testis and Epididymis and Is Not Regulated by Testicular or Pituitary Factors

  2000cites this paper